Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?

Heart. 2017 Aug;103(15):1143-1145. doi: 10.1136/heartjnl-2017-311197. Epub 2017 May 20.
No abstract available

Keywords: Acute coronary syndromes; Coronary artery disease.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Aspirin
  • Drug Therapy, Combination
  • Humans
  • Platelet Aggregation Inhibitors
  • Ticlopidine*

Substances

  • Platelet Aggregation Inhibitors
  • Ticlopidine
  • Aspirin